(NASDAQ: BDSX) Biodesix's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 36.3%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 55.34%.
Biodesix's earnings in 2025 is -$41,078,000.On average, 1 Wall Street analyst forecast BDSX's earnings for 2025 to be -$42,523,674, with the lowest BDSX earnings forecast at -$42,523,674, and the highest BDSX earnings forecast at -$42,523,674.
In 2026, BDSX is forecast to generate -$27,860,338 in earnings, with the lowest earnings forecast at -$27,860,338 and the highest earnings forecast at -$27,860,338.